HOME >> MEDICINE >> NEWS
Alzheimer's disease center seeks patients for new drug studies

will prove beneficial to at least some of the patients who experience the devastating symptoms of Alzheimer's."

Svetlik said the clinic also has several other drug trials under way. Only one Alzheimer's medication, Cognex, has received approval from the Food and Drug Administration. About 25 percent of Alzheimer's patients can tolerate an adequate dose of Cognex, and a quarter of those have shown improvement, Svetlik said.

"After Cognex was approved, we had difficulty recruiting for other drug studies because everyone wanted to be on that drug," she said. "We're now starting to get more interest in these new studies as people realize that one drug doesn't work for everybody."

The cause of Alzheimer's is still a mystery although researchers have made progress in understanding the role played by genes. The new generation of medications target various sections of the brain that degenerate during the course of the disease.

Alzheimer's disease affects approximately 4 million Americans. The UT Southwestern clinic currently sees about 300 patients.

For more information about the new drug studies and other clinic research, call (214) 648-8696.


'"/>

Contact: Emily Martinez
emart2@mednet.swmed.edu
214-648-3404
UT Southwestern Medical Center
28-Aug-1996


Page: 1 2

Related medicine news :

1. Chemical decoy shows promise for slowing Alzheimers by acting as decoy
2. Neuronal death and processing of Tau protein in Alzheimers disease
3. Researchers discover link between insulin and Alzheimers
4. New trials for counseling caregivers and patients with Alzheimers begin
5. Marijuana ingredient may stall decline from Alzheimers
6. Drugs used to treat Alzheimers in nursing homes are worsening sufferers illness
7. UT Southwestern doctors track Oklahoma Alzheimers patients via telemedicine
8. Contrary to previous findings, smoking is detrimental to patients with Alzheimers
9. Nanoscale diagnostic sets sights on Alzheimers
10. New test is first step in early detection of Alzheimers disease
11. Older people with the Alzheimers gene find it harder to remember to remember even if healthy

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Alzheimer disease center seeks patients for new drug studies

(Date:10/30/2014)... (PRWEB) October 30, 2014 Dr. Joseph Furlin ... new website for his practices; OB GYN in Melrose ... . This website contains important information about each of ... well as downloadable patient forms in English and Spanish. ... the service pages on the website provide Dr. Furlin’s patients ...
(Date:10/30/2014)... (PRWEB) October 30, 2014 Global prebiotics ... 2020, according to a new study by Grand View ... surging demand for sugar and fat free products owing ... the demand for prebiotics over the forecast period. , ... , Food & beverage was the largest application ...
(Date:10/30/2014)... 30, 2014 REV'D Provision Co. announced ... available through a unique service called, The Feed ... empower the everyday athlete. The Feed has taken the ... created a system to pass that information on to ... is now available on The Feed!” says REV’D® marketing ...
(Date:10/30/2014)... York (PRWEB) October 30, 2014 The ... (NAMS) came to a close on Saturday, October ... since the Society’s inception in 1989. NAMS is North ... and quality of life of all women during midlife ... aging. With over 2,000 physicians and thought leaders from ...
(Date:10/30/2014)... (PRWEB) October 30, 2014 Sound Telecom, a ... infographic that will assist people any time they wonder, “Should ... the right answer by leading them through a series of ... to their initial query. , There are many considerations and ... to use an answering service . This decision infographic ...
Breaking Medicine News(10 mins):Health News:Dr. Joseph Furlin Launches New Website with Information about Care Services 2Health News:Prebiotics Market Is Expected To Grow At A CAGR Of 9.3% From 2014 To 2020: Grand View Research, Inc. 2Health News:Prebiotics Market Is Expected To Grow At A CAGR Of 9.3% From 2014 To 2020: Grand View Research, Inc. 3Health News:Prebiotics Market Is Expected To Grow At A CAGR Of 9.3% From 2014 To 2020: Grand View Research, Inc. 4Health News:Prebiotics Market Is Expected To Grow At A CAGR Of 9.3% From 2014 To 2020: Grand View Research, Inc. 5Health News:Nutrition Experts at TheFeed.com Get REV'D 2Health News:Nutrition Experts at TheFeed.com Get REV'D 3Health News:Highlights from The North American Menopause Society 25th Annual Meeting 2Health News:Highlights from The North American Menopause Society 25th Annual Meeting 3Health News:Sound Telecom Produces Decision Infographic to Aid Businesses 2
(Date:10/30/2014)... -- WuXi PharmaTech (Cayman) Inc. (NYSE: WX ), ... serving the pharmaceutical, biotechnology, and medical device industries, with ... the United States , today announced the ... Tel Aviv area of Israel.  ... of integrated R&D services to local customers. It will ...
(Date:10/30/2014)... 30, 2014   ViaDerma, Inc. (OTCQB: ... new products to market, has recently released a ... is a topical liquid tetracycline-based antibiotic that uses ... convert oral medication active ingredients into topical drugs. ... aid antibiotic to help prevent skin infection in ...
(Date:10/30/2014)... 2014 Molecular Profiles Ltd., a subsidiary of ... Maryland -based Xceleron have announced a ... clinical development that will be launched at AAPS in ... This partnership extends Molecular Profiles, new ROADMAP to ... this month. The company also has complementary collaborations in ...
Breaking Medicine Technology:WuXi AppTec Launches Representative Office in Israel, Forms Strategic Collaboration with Pontifax 2ViaDerma, Inc. Lead Product TetraStem Shown Effective in Fighting Staph Infections including MRSA 2ViaDerma, Inc. Lead Product TetraStem Shown Effective in Fighting Staph Infections including MRSA 3Molecular Profiles To Launch US Strategic Alliance At AAPS 2Molecular Profiles To Launch US Strategic Alliance At AAPS 3
Cached News: